BMY vs HWKN · P/E 17, rev $24.46B vs P/E 40, rev $1.08B
Bristol-Myers Squibb Company (BMY) versus Hawkins Inc (HWKN) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Hawkins Inc (HWKN) is a specialty chemicals company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported HWKN revenue for 2026-03-29 was $1.08B. Net income was $81.5M. Revenue was up 11.2% from 2025-03-30 to 2026-03-29. HWKN currently screens at market cap $3.24B and trailing P/E 39.7.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. HWKN currently screens at market cap $3.24B and trailing P/E 39.7.
Not investment advice. Open the BMY and HWKN stock pages for the full models.
Not investment advice.